
Debiganto 110mg Tablet
Marketer
Shinto Organics (P) Limited
Salt Composition
Dabigatran Etexilate (110mg)
Overview Debiganto 110mg Tablet
Anticoagulant medication, Ariclot 110mg tablets, prevents and manages blood clot formation. This helps lower the risk of stroke and heart attack by inhibiting clots in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent clot development, it also minimizes clotting risks post-knee or hip replacement. Administer with or without food, consistently at the same time daily. Long-term use, potentially lifelong, may be necessary; discontinuing or altering dosage without physician consultation significantly increases heart attack, stroke, or thrombosis risk. Lifestyle modifications—such as abstaining from smoking, adopting a balanced diet, engaging in regular exercise, and managing weight—further reduce clot risk. Common side effects include gastrointestinal discomfort and increased bleeding susceptibility (nosebleeds, bruising). Report any adverse effects immediately. Additional potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindicated in patients with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't typically required.
Uses of Debiganto 110mg Tablet
Preventing and managing blood clots
Major Benefits of Debiganto 110mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 110mg Debiganto tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Debiganto 110mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Debiganto 110mg Tablet:
Consume this medication according to your doctor's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Debiganto 110mg Tablets can be administered with or without food, although consistent timing is recommended.
How Debiganto 110mg Tablet works:
Xylotol 110mg tablets are a new type of blood thinner, specifically a novel oral anticoagulant (NOAC), that acts by inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Debiganto 110mg Tablet is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Debiganto 110mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Debiganto 110mg Tablet while breastfeeding is likely unsafe. Studies in humans indicate potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Debiganto 110mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Debiganto 110mg tablets, potentially requiring dosage modification. Physician consultation is advised. Debiganto 110mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Debiganto 110mg tablets; dosage modification may be necessary. A physician's consultation is advised.
What if you forget to take Debiganto 110mg Tablet :
Should you forget to take your Debiganto 110mg Tablet, administer it as promptly as possible that day. However, omit the missed dose if it's less than 6 hours until your next scheduled intake. Never take a double dose to compensate for a missed one.
Facts to Know About Debiganto 110mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Oral direct thrombin inhibitor |
